Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Novel Coronavirus 2019

   
 
Travel Procedures and Informations
Procedures for All Incoming Passengers to Lebanon

 
 
Memos and Decisions:
 

PCR Results of Incoming Passengers:
 
 
 
Surveillance Reports
 
 
Suppressing COVID-19 Transmission
        
For the Public
Questions and Answers:

Health Tips:  
Mental health during COVID-19 outbreak

Abiding by COVID-19 Preventive Measures During Ramadan 2022

Circulars and Memorandom:



































































































 

























 









 

















































 
For the Professionals
 
 
Tuberculosis and Corona
 
 
Noncommunicable Diseases and the Corona Virus Disease 2019 (COVID-19)
 
Monitoring of COVID-19 Infection In Lebanon 
 
 
Statements
 
 
Meetings of the National Infectious Disease Committee
 
 
Laws and Regulations
مكافحة الأمراض والأوبئة
 
 

For any inquiry or clarification regarding the new coronavirus 2019-nCoV,  please contact the Ministry of Public Health on the following:

 
  • New Hotline:1787
  • Hotline for the Patient Admission to Hospitals: 01/832700
  • Service of Preventive Medicine: 01/843769 - 01/830300 Ext: 435-436-437
  • Center of the Quarantine at Beirut Airport: 01/629352
  • Epidemiological Surveillance Program: 01/614194 - 01/614196
    ...
    59
    ...
ATC Name B/G Ingredients Dosage Form Price
L04AD02 ROLITAC XR G Tacrolimus - 0.5mg 0.5mg Capsule, hard, prolonged release 6,329,498 L.L
L04AD02 PROGRAF 0.5 MG B Tacrolimus - 0.5mg 0.5mg Capsule L.L
L04AD02 PROGRAF 1MG B Tacrolimus - 1mg 1mg Capsule L.L
L04AD02 PROGRAF 5MG B Tacrolimus - 5mg 5mg Capsule L.L
L04AD02 ADVAGRAF B Tacrolimus monohydrate - 1mg 1mg Capsule, prolonged release L.L
L04AD02 ADVAGRAF B Tacrolimus monohydrate - 3mg 3mg Capsule, prolonged release L.L
L04AD01 SANDIMMUN NEORAL SOFT GELATIN B Ciclosporin - 50mg 50mg Capsule, soft gelatin 4,309,703 L.L
L04AD01 SANDIMMUN NEORAL SOFT GELATIN B Ciclosporin - 25mg 25mg Capsule, soft gelatin 2,385,320 L.L
L04AD01 SANDIMMUN NEORAL SOFT GELATIN B Ciclosporin - 100mg 100mg Capsule, soft gelatin 8,264,592 L.L
L04AD01 SANDIMMUN NEORAL B Ciclosporin - 100mg/ml 100mg/ml Solution 8,264,592 L.L
L04AD01 SANDIMMUN B Ciclosporin - 50mg/ml 250mg/5ml Injectable concentrated solution 6,992,013 L.L
L04AC18 SKYRIZI BioTech Risankizumab - 150mg 150mg Injectable solution 276,469,860 L.L
L04AC16 TREMFYA BioTech Guselkumab - 100mg/ml 100mg/ml Injectable solution L.L
L04AC16 TREMFYA BioTech Guselkumab - 100mg/ml 100mg/ml Injectable solution 190,195,151 L.L
L04AC16 TREMFYA BioTech Guselkumab - 100mg/ml 100mg/ml Injectable solution 190,195,151 L.L
L04AC13 TALTZ BioTech Ixekizumab - 80mg/ml 80mg/ml Injectable solution 85,080,792 L.L
L04AC10 COSENTYX BioTech Secukinumab - 150mg/ml 150mg/ml Injectable solution L.L
L04AC10 COSENTYX BioTech Secukinumab - 150mg/ml 150mg/ml Injectable solution 102,120,767 L.L
L04AC07 ACTEMRA BioTech Tocilizumab - 80mg/4ml 80mg/4ml Injectable concentrated solution L.L
L04AC07 ACTEMRA BioTech Tocilizumab - 162mg/0.9ml 162mg/0.9ml Injectable solution L.L
L04AC07 ACTEMRA BioTech Tocilizumab - 200mg/10ml 200mg/10ml Injectable concentrated solution L.L
L04AC07 ACTEMRA BioTech Tocilizumab - 400mg/20ml 400mg/20ml Injectable concentrated solution L.L
L04AC07 ACTEMRA BioTech Tocilizumab - 80mg/4ml 80mg/4ml Injectable concentrated solution 11,127,864 L.L
L04AC07 ACTEMRA BioTech Tocilizumab - 162mg/0.9ml 162mg/0.9ml Injectable solution 79,959,812 L.L
L04AC07 ACTEMRA BioTech Tocilizumab - 200mg/10ml 200mg/10ml Injectable concentrated solution 25,485,937 L.L
L04AC07 ACTEMRA BioTech Tocilizumab - 400mg/20ml 400mg/20ml Injectable concentrated solution 47,925,322 L.L
L04AC05 STELARA BioTech Ustekinumab - 90mg 90mg Injectable solution L.L
L04AC05 STELARA BioTech Ustekinumab - 130mg 130mg Injectable concentrate for solution L.L
L04AC05 STELARA BioTech Ustekinumab - 45mg 45mg Injectable solution L.L
L04AC05 STELARA BioTech Ustekinumab - 45mg 45mg Injectable solution 157,788,141 L.L
    ...
    59
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2026